Liminal BioSciences Inc.

LMNL · NASDAQ
Analyze with AI
6/30/2023
3/31/2023
12/31/2022
9/30/2022
Operating Activities
Net Income-$9-$7-$4$22
Dep. & Amort.$0$0$0$0
Deferred Tax-$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$1$0-$1-$2
Other Non-Cash$0-$4-$2-$33
Operating Cash Flow-$8-$10-$6-$12
Investing Activities
PP&E Inv.$0$0$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$3$0
Investing Cash Flow$0$0$3$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$0-$0-$6
Financing Cash Flow-$0-$0-$0-$6
Forex Effect$0$0-$1$2
Net Chg. in Cash-$8-$10-$4-$15
Supplemental Information
Beg. Cash$27$37$41$56
End Cash$19$27$37$41
Free Cash Flow-$8-$10-$6-$12
Liminal BioSciences Inc. (LMNL) Financial Statements & Key Stats | AlphaPilot